The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Zirpine 10mg Tablets

10 milligram(s) Tablet

Pinewood Laboratories Ltd,PA0281/110/001

Main Information

Trade NameZirpine 10mg Tablets
Active SubstancesCetirizine dihydrochloride
Strength10 milligram(s)
Dosage FormTablet
Licence HolderPinewood Laboratories Ltd,
Licence NumberPA0281/110/001

Group Information

ATC CodeR06AE Piperazine derivatives
R06AE07 cetirizine


Licence Issued08/03/2002
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceRetail sale through pharmacies only in pack sizes not exceeding 10 tablets As a prescription-only item in pack sizes exceeding 10 tablets
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0088-002-003
Interchangeable List DocumentPDF of Interchangeable List
« Back